MINPP1 and hepatocellular carcinoma: In this study, we uncovered a novel tumorigenesis axis, namely HBp/FOXO3/miRNA-30b-5p/MINPP1 which promotes the progression of HBV-positive HCC through glycolytic bypass and is limited to HBV-related HCC.